Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 326 participants.
Also called NCT04493840
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 326 participants
- Sponsor
- Registry
-
NCT04493840
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04493840. Randomized; triple masking; primary purpose treatment. Start 2020-07-30 (actual); primary completion 2022-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury
- Acronym
- RESTORE
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Shenfu Injection
- Intervention (Drug)
- 5% Glucose Injection
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct04493840- Content hash
8f3212a2d54849a862286600113d7c4bfcf223d4c4c3d5ea38ac31e8d7dd47cd